A Phase I, Single and Fractionated, Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of an Erythropoietin Mimetic Antibody Fusion Protein (CNTO 528) in Healthy Male Subjects

2008 ◽  
Vol 48 (10) ◽  
pp. 1197-1207 ◽  
Author(s):  
Esther Bouman-Thio ◽  
Kari Franson ◽  
Bruce Miller ◽  
John Getsy ◽  
Adam Cohen ◽  
...  
Keyword(s):  
Fusion Protein ◽  
Phase I ◽  
Healthy Male ◽  
Dose Study ◽  
Antibody Fusion Protein ◽  
Male Subjects

A phase I, first-in-human single ascending dose study of the MEK inhibitor WX-554 given to healthy male subjects.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e13666-e13666 ◽  
Author(s):  
C. Mala ◽  
N. G. Neville ◽  
E. Haindl ◽  
M. Buergle ◽  
W. Schmalix ◽  
...  
Keyword(s):  
Phase I ◽  
Mek Inhibitor ◽  
Healthy Male ◽  
Dose Study ◽  
Male Subjects ◽  
Single Ascending Dose Study

884: Phase I, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Investigate the Safety, Tolerability, and Pharmacokinetics of DA-8159

2004 ◽  
Vol 171 (4S) ◽  
pp. 234-234 ◽  
Author(s):  
Harin Padma-Nathan ◽  
Jae Seung Pacik ◽  
Byoung Ok Ahn ◽  
Kyung Koo Kang ◽  
Mi Young Bahng ◽  
...  
Keyword(s):  
Phase I ◽  
Controlled Study ◽  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Male Subjects

A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjects

2020 ◽  
Vol 85 (5) ◽  
pp. 995-1001 ◽  
Author(s):  
Ken Ogasawara ◽  
Bradley Vince ◽  
Christine Xu ◽  
Meng Zhang ◽  
Maria Palmisano ◽  
...  
Keyword(s):  
Single Dose ◽  
Phase I ◽  
Phase I Study ◽  
Healthy Male ◽  
Oral Doses ◽  
Male Subjects
Sign in / Sign up

Export Citation Format

Share Document